Tissue and Cell Extraction and Purification |
EP10011 |
Neuromics |
100 Tests |
EUR 444.6 |
All Competitors Laboratories manufactures the antibodyb reagents distributed by Genprice. The Antibodyb reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact All Competitors. Other Antibodyb products are available in stock. Specificity: Antibodyb Category:
Porcine True insulin ELISA kit |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Goat True insulin ELISA kit |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Serum / Plasma information
SMAD4 antibody | 1B6 |
MBS226479-01mL |
MyBiosource |
0.1mL |
EUR 485 |
SMAD4 antibody | 1B6 |
MBS226479-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2015 |
STAT3 antibody | 3B5 |
MBS226488-01mL |
MyBiosource |
0.1mL |
EUR 485 |
STAT3 antibody | 3B5 |
MBS226488-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2015 |
TIGIT Antibody [3B5] |
MBS154590-01mg |
MyBiosource |
0.1mg |
EUR 500 |
TIGIT Antibody [3B5] |
MBS154590-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2230 |
LAG3 Antibody [6B12] |
MBS154613-01mg |
MyBiosource |
0.1mg |
EUR 500 |
LAG3 Antibody [6B12] |
MBS154613-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2230 |
TIM-3 Antibody [1B10] |
MBS154633-01mg |
MyBiosource |
0.1mg |
EUR 500 |
TIM-3 Antibody [1B10] |
MBS154633-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2230 |
TIGIT Antibody [2B5] |
SD8824-002mg |
ProSci |
0.02 mg |
EUR 253.22 |
|
Description: TIGIT Antibody: The T cell immunoreceptor with Ig and ITIM domains (TIGIT) is a member of the PVR (poliovirus receptor) family of immunoglobin proteins. It is expressed on several classes of T cells including follicular B helper T cells (TFH). TIGIT has been shown to bind PVR with high affinity; this binding is thought to assist interactions between TFH and dendritic cells to regulate T cell dependent B cell responses (1). Similar to other immune checkpoint proteins such as PD-1, TIGIT is upregulated on exhausted T cells in chronic viral infections and cancer. Blockade of both TIGIT and PD-1 pathways leads to tumor rejection in mice suggesting that it may be of therapeutic use against cancer (2). |
TIGIT Antibody [2B5] |
SD8824-01mg |
ProSci |
0.1 mg |
EUR 723.62 |
|
Description: TIGIT Antibody: The T cell immunoreceptor with Ig and ITIM domains (TIGIT) is a member of the PVR (poliovirus receptor) family of immunoglobin proteins. It is expressed on several classes of T cells including follicular B helper T cells (TFH). TIGIT has been shown to bind PVR with high affinity; this binding is thought to assist interactions between TFH and dendritic cells to regulate T cell dependent B cell responses (1). Similar to other immune checkpoint proteins such as PD-1, TIGIT is upregulated on exhausted T cells in chronic viral infections and cancer. Blockade of both TIGIT and PD-1 pathways leads to tumor rejection in mice suggesting that it may be of therapeutic use against cancer (2). |
LAG-3 Antibody [2B11] |
SD8841-002mg |
ProSci |
0.02 mg |
EUR 253.22 |
|
Description: The lymphocyte activation gene-3 (LAG3) is a member of the immunoglobulin superfamily and binds MHC class II with high affinity (1), negatively regulating T-cell function and homeostasis (2). It is expressed in B, T, and NK cells, monocytes, and dendritic cells (3), and acts to regulate T cell expansion (4). LAG3 is also an important immune checkpoint protein, with anti-LAG3 antibodies activating T effector cells and affecting regulatory T cell functions. Furthermore LAG3 appears to act in a synergistic fashion with PD-1/PD-L1, suggesting that a dual antibody approach may prove useful in cancer immunotherapy. |
LAG-3 Antibody [2B11] |
SD8841-01mg |
ProSci |
0.1 mg |
EUR 723.62 |
|
Description: The lymphocyte activation gene-3 (LAG3) is a member of the immunoglobulin superfamily and binds MHC class II with high affinity (1), negatively regulating T-cell function and homeostasis (2). It is expressed in B, T, and NK cells, monocytes, and dendritic cells (3), and acts to regulate T cell expansion (4). LAG3 is also an important immune checkpoint protein, with anti-LAG3 antibodies activating T effector cells and affecting regulatory T cell functions. Furthermore LAG3 appears to act in a synergistic fashion with PD-1/PD-L1, suggesting that a dual antibody approach may prove useful in cancer immunotherapy. |
TIGIT Antibody [3B5] |
RF16053-002mg |
ProSci |
0.02 mg |
EUR 229.7 |
|
Description: TIGIT Antibody: The T cell immunoreceptor with Ig and ITIM domains (TIGIT) is a member of the PVR (poliovirus receptor) family of immunoglobin proteins. It is expressed on several classes of T cells including follicular B helper T cells (TFH). TIGIT has been shown to bind PVR with high affinity; this binding is thought to assist interactions between TFH and dendritic cells to regulate T cell dependent B cell responses (1). Similar to other immune checkpoint proteins such as PD-1, TIGIT is upregulated on exhausted T cells in chronic viral infections and cancer. Blockade of both TIGIT and PD-1 pathways leads to tumor rejection in mice suggesting that it may be of therapeutic use against cancer (2). |
TIGIT Antibody [3B5] |
RF16053-01mg |
ProSci |
0.1 mg |
EUR 594.26 |
|
Description: TIGIT Antibody: The T cell immunoreceptor with Ig and ITIM domains (TIGIT) is a member of the PVR (poliovirus receptor) family of immunoglobin proteins. It is expressed on several classes of T cells including follicular B helper T cells (TFH). TIGIT has been shown to bind PVR with high affinity; this binding is thought to assist interactions between TFH and dendritic cells to regulate T cell dependent B cell responses (1). Similar to other immune checkpoint proteins such as PD-1, TIGIT is upregulated on exhausted T cells in chronic viral infections and cancer. Blockade of both TIGIT and PD-1 pathways leads to tumor rejection in mice suggesting that it may be of therapeutic use against cancer (2). |
LAG3 Antibody [6B12] |
RF16086-002mg |
ProSci |
0.02 mg |
EUR 229.7 |
|
Description: The lymphocyte activation gene-3 (LAG3) is a member of the immunoglobulin superfamily and binds MHC class II with high affinity (1), negatively regulating T-cell function and homeostasis (2). It is expressed in B, T, and NK cells, monocytes, and dendritic cells (3), and acts to regulate T cell expansion (4). LAG3 is also an important immune checkpoint protein, with anti-LAG3 antibodies activating T effector cells and affecting regulatory T cell functions. Furthermore LAG3 appears to act in a synergistic fashion with PD-1/PD-L1, suggesting that a dual antibody approach may prove useful in cancer immunotherapy. |